MaxCyte
MXCT
$4.48
Share price
8.58%
Change (1 day)
-34.63%
Change (1 year)
Categories
Revenue for MaxCyte (MXCT)
Revenue in 2024 (TTM): NZ$64.39 Million
According to MaxCyte's latest financial reports the company's current revenue (TTM 
) is NZ$68.47 Million. an increase over the revenue in the year 2023 that were of NZ$65.28 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MaxCyte from 2021 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$68.49 M | 4.91% |
| 2023 | NZ$65.28 M | -6.35% |
| 2022 | NZ$69.71 M | 40.49% |
| 2021 | NZ$49.62 M |